- Home
- EVAX vs EFOI Comparison
EVAX vs EFOI Comparison
Compare EVAX & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- EFOI
- Stock Information
- Founded
- EVAX 2008
- EFOI 1985
- Country
- EVAX Denmark
- EFOI United States
- Employees
- EVAX N/A
- EFOI N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- EFOI Building Products
- Sector
- EVAX Health Care
- EFOI Consumer Discretionary
- Exchange
- EVAX Nasdaq
- EFOI Nasdaq
- Market Cap
- EVAX 8.7M
- EFOI 7.9M
- IPO Year
- EVAX 2021
- EFOI 1994
- Fundamental
- Price
- EVAX $0.89
- EFOI $1.24
- Analyst Decision
- EVAX Strong Buy
- EFOI
- Analyst Count
- EVAX 2
- EFOI 0
- Target Price
- EVAX $11.00
- EFOI N/A
- AVG Volume (30 Days)
- EVAX 82.5K
- EFOI 5.5K
- Earning Date
- EVAX 10-31-2024
- EFOI 11-12-2024
- Dividend Yield
- EVAX N/A
- EFOI N/A
- EPS Growth
- EVAX N/A
- EFOI N/A
- EPS
- EVAX N/A
- EFOI N/A
- Revenue
- EVAX $3,295,000.00
- EFOI $5,975,000.00
- Revenue This Year
- EVAX $4,845.21
- EFOI N/A
- Revenue Next Year
- EVAX $30.30
- EFOI N/A
- P/E Ratio
- EVAX N/A
- EFOI N/A
- Revenue Growth
- EVAX N/A
- EFOI 49.86
- 52 Week Low
- EVAX $0.85
- EFOI $1.14
- 52 Week High
- EVAX $13.61
- EFOI $2.90
- Technical
- Relative Strength Index (RSI)
- EVAX 21.83
- EFOI 42.05
- Support Level
- EVAX $0.85
- EFOI $1.26
- Resistance Level
- EVAX $0.96
- EFOI $1.45
- Average True Range (ATR)
- EVAX 0.15
- EFOI 0.11
- MACD
- EVAX -0.00
- EFOI -0.02
- Stochastic Oscillator
- EVAX 5.75
- EFOI 6.25
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. It serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, wall-packs, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. It generates a majority of its sales from Military maritime products in the United States.